# The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase

> **NCT03907436** · NA · COMPLETED · sponsor: **University of California, Irvine** · enrollment: 30 (actual)

## Conditions studied

- Myeloproliferative Disorder
- Myeloproliferative Syndrome
- Myelofibrosis
- Polycythemia Vera
- Essential Thrombocythemia

## Interventions

- **OTHER:** USDA Diet
- **OTHER:** Mediterranean Diet

## Key facts

- **NCT ID:** NCT03907436
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-10-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03907436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03907436, "The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03907436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*